{"transactions":[{"id":4638090,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-10-08T21:29:22.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":18.1,"value":872401.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.87 to $18.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":471301,"source":{"system":"sec-edgar","filing":"0001193125-26-418096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526418096/ownership.xml","form_type":"4"}},{"id":4613275,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-09T20:12:38.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":18.94,"value":912889.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.33 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":519500,"source":{"system":"sec-edgar","filing":"0001193125-26-386455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526386455/ownership.xml","form_type":"4"}},{"id":684475,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-18T20:17:50.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":20.33,"value":979885.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.56 to $20.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":567699,"source":{"system":"sec-edgar","filing":"0001193125-26-355502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526355502/ownership.xml","form_type":"4"}},{"id":713120,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-08T21:08:20.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":48199,"price":19.58,"value":943736.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $18.52 to $20.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":615898,"source":{"system":"sec-edgar","filing":"0001193125-26-298681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526298681/ownership.xml","form_type":"4"}},{"id":713119,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-08T21:08:20.000Z","date":"2026-06-30","kind":"grant","planned":true,"acquired":true,"shares":3056,"price":6.95,"value":21239.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on January 2, 2026."}],"balance_after":664097,"source":{"system":"sec-edgar","filing":"0001193125-26-298681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526298681/ownership.xml","form_type":"4"}},{"id":938758,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-15T21:13:30.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":1450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":1450000,"derivative":{"exercise_price":7.94,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":1450000},"source":{"system":"sec-edgar","filing":"0001193125-26-014109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526014109/ownership.xml","form_type":"4"}},{"id":945155,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-07T21:15:03.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":43168,"price":7.82,"value":337573.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."}],"balance_after":661041,"source":{"system":"sec-edgar","filing":"0001193125-26-006328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526006328/ownership.xml","form_type":"4"}},{"id":945154,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-07T21:15:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":994,"price":2.99,"value":2972.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 136,854 shares underlying restricted stock units (\"RSUs\")."}],"balance_after":704209,"source":{"system":"sec-edgar","filing":"0001193125-26-006328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312526006328/ownership.xml","form_type":"4"}},{"id":1008805,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-04T21:10:37.000Z","date":"2025-11-03","kind":"sale","planned":false,"acquired":false,"shares":62073,"price":7,"value":434511.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,853 shares of restricted stock units (\"RSUs\") on October 31, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,854 shares underlying RSUs."}],"balance_after":703215,"source":{"system":"sec-edgar","filing":"0001193125-25-264700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000119312525264700/ownership.xml","form_type":"4"}},{"id":1089700,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-10T20:55:22.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":18639,"price":3.57,"value":66541.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 273,707 shares underlying RSUs."}],"balance_after":765288,"source":{"system":"sec-edgar","filing":"0000950170-25-095093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025095093/ownership.xml","form_type":"4"}},{"id":1089699,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-10T20:55:22.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":42740,"price":3.57,"value":152581.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units (\"RSUs\") on July 8, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 315,265 shares underlying RSUs."}],"balance_after":783927,"source":{"system":"sec-edgar","filing":"0000950170-25-095093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025095093/ownership.xml","form_type":"4"}},{"id":1098496,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-01T20:59:29.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 410,560 shares underlying RSUs."}],"balance_after":826667,"source":{"system":"sec-edgar","filing":"0000950170-25-092305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025092305/ownership.xml","form_type":"4"}},{"id":1166749,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-24T20:03:43.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":18653,"price":2.97,"value":55399.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 410,560 shares underlying RSUs."}],"balance_after":821667,"source":{"system":"sec-edgar","filing":"0000950170-25-057996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025057996/ownership.xml","form_type":"4"}},{"id":1166748,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-24T20:03:43.000Z","date":"2025-04-23","kind":"sale","planned":false,"acquired":false,"shares":42769,"price":2.97,"value":127023.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units (\"RSUs\") on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 452,118 shares underlying RSUs."}],"balance_after":840320,"source":{"system":"sec-edgar","filing":"0000950170-25-057996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025057996/ownership.xml","form_type":"4"}},{"id":1270271,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-14T01:56:51.000Z","date":"2025-02-13","kind":"sale","planned":false,"acquired":false,"shares":75324,"price":3.7,"value":278698.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 166,232 shares of RSUs on February 12, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 547,413 shares underlying RSUs."}],"balance_after":883089,"source":{"system":"sec-edgar","filing":"0000950170-25-020272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025020272/ownership.xml","form_type":"4"}},{"id":1270270,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-14T01:56:51.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":332465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 713,645 shares underlying RSUs."}],"balance_after":958413,"source":{"system":"sec-edgar","filing":"0000950170-25-020272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025020272/ownership.xml","form_type":"4"}},{"id":1270269,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-14T01:56:51.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":140182,"price":3.85,"value":539700.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 381,180 shares of restricted stock units (\"RSUs\") on February 10, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 381,180 shares underlying RSUs."}],"balance_after":625948,"source":{"system":"sec-edgar","filing":"0000950170-25-020272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025020272/ownership.xml","form_type":"4"}},{"id":1296914,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-24T00:01:20.000Z","date":"2025-01-23","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":4.78,"value":597500.0,"ownership":{"direct":false,"nature":"By The Patel Family Irrevocable Trust of 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Patel Family Irrevocable Trust of 2019 (the \"Trust\") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $4.62 to $4.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":199548,"source":{"system":"sec-edgar","filing":"0000950170-25-008451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025008451/ownership.xml","form_type":"4"}},{"id":1296913,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-24T00:01:20.000Z","date":"2025-01-22","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":4.8,"value":600000.0,"ownership":{"direct":false,"nature":"By The Patel Family Irrevocable Trust of 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Patel Family Irrevocable Trust of 2019 (the \"Trust\") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $4.65 to $4.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":324548,"source":{"system":"sec-edgar","filing":"0000950170-25-008451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025008451/ownership.xml","form_type":"4"}},{"id":1296912,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-24T00:01:20.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":4.52,"value":565000.0,"ownership":{"direct":false,"nature":"By The Patel Family Irrevocable Trust of 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Patel Family Irrevocable Trust of 2019 (the \"Trust\") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.35 to $4.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":449548,"source":{"system":"sec-edgar","filing":"0000950170-25-008451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025008451/ownership.xml","form_type":"4"}},{"id":1303896,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-15T02:00:06.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":1105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 10, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":1105000,"derivative":{"exercise_price":4.45,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":1105000},"source":{"system":"sec-edgar","filing":"0000950170-25-005566","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017025005566/ownership.xml","form_type":"4"}},{"id":1327364,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-18T21:51:42.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":5,"value":500000.0,"ownership":{"direct":false,"nature":"By The Patel Family Irrevocable Trust of 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the Patel Family Irrevocable Trust of 2019 (the \"Trust\") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":574548,"source":{"system":"sec-edgar","filing":"0000950170-24-137960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024137960/ownership.xml","form_type":"4"}},{"id":1447528,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-26","kind":"exercise","planned":true,"acquired":false,"shares":36706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vested in sixteen (16) equal quarterly installments after April 23, 2019."}],"balance_after":482073,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":36706},"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1447527,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vested in sixteen (16) equal quarterly installments after April 23, 2019."}],"balance_after":518779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1447526,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-26","kind":"sale","planned":true,"acquired":false,"shares":36706,"price":9.07,"value":332923.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $9.00 to $9.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762,360 shares underlying restricted stock units."}],"balance_after":766130,"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1447525,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-26","kind":"exercise","planned":true,"acquired":true,"shares":36706,"price":5.04,"value":184998.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762,360 shares underlying restricted stock units."}],"balance_after":802836,"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1447524,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-25","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.16,"value":458000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.00 to $9.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762,360 shares underlying restricted stock units."}],"balance_after":766130,"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1447523,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-29T22:37:35.000Z","date":"2024-07-25","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":5.04,"value":252000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762,360 shares underlying restricted stock units."}],"balance_after":816130,"source":{"system":"sec-edgar","filing":"0000950170-24-087435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024087435/ownership.xml","form_type":"4"}},{"id":1466544,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-01T20:43:58.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":2108,"price":5.54,"value":11678.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 762,360 shares underlying restricted stock units."}],"balance_after":766130,"source":{"system":"sec-edgar","filing":"0000950170-24-079693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000095017024079693/ownership.xml","form_type":"4"}},{"id":1677061,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-18T21:19:55.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":762360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 762,360 shares underlying RSUs."}],"balance_after":764022,"source":{"system":"sec-edgar","filing":"0001209191-24-001843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919124001843/doc4.xml","form_type":"4"}},{"id":1771773,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-29T21:27:34.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1662,"price":10.68,"value":17750.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2023."}],"balance_after":1662,"source":{"system":"sec-edgar","filing":"0001209191-23-050874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123050874/doc4.xml","form_type":"4"}},{"id":2025307,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-09","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":568779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025306,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-08","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":582779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025305,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":596779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025304,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":14000,"price":20.55,"value":287700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $20.25 to $20.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025303,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-09","kind":"exercise","acquired":true,"shares":14000,"price":5.04,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025302,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":14000,"price":20.98,"value":293720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.73 to $21.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025301,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-08","kind":"exercise","acquired":true,"shares":14000,"price":5.04,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025300,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":14000,"price":21.45,"value":300300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.25 to $21.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2025299,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-09T22:09:20.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":14000,"price":5.04,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-23-008072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123008072/doc4.xml","form_type":"4"}},{"id":2040770,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-31T21:27:04.000Z","date":"2022-10-28","kind":"gift","acquired":true,"shares":254554,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The SSP Irrevocable Trust of 2020"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held in an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":687355,"source":{"system":"sec-edgar","filing":"0001209191-23-005702","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123005702/doc5.xml","form_type":"5"}},{"id":2040769,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-31T21:27:04.000Z","date":"2022-10-28","kind":"gift","acquired":false,"shares":254554,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-005702","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123005702/doc5.xml","form_type":"5"}},{"id":2051538,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":701680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Such option was granted pursuant to the terms of the Issuer's 2020 Stock Option and Incentive Plan and becomes exercisable, if at all, in twelve equal quarterly installments if the last quoted trading price per share of the Issuer's common stock on the Nasdaq Global Market during any fifteen consecutive calendar day period is at least $35.00; provided that the reporting person maintains a service relationship with the Issuer."}],"balance_after":701680,"derivative":{"exercise_price":20.45,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":701680},"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051537,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":701680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 17, 2023, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":701680,"derivative":{"exercise_price":20.45,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":701680},"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051536,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-19","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":610779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051535,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-18","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":638779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051534,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":666779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051533,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":28000,"price":20.02,"value":560560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20 to $20.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051532,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-19","kind":"exercise","acquired":true,"shares":28000,"price":5.04,"value":141120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":282554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051531,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":28000,"price":20.87,"value":584360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.35 to $21.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051530,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-18","kind":"exercise","acquired":true,"shares":28000,"price":5.04,"value":141120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":282554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051529,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":28000,"price":20.23,"value":566440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2051528,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-20T01:33:03.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":28000,"price":5.04,"value":141120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":282554,"source":{"system":"sec-edgar","filing":"0001209191-23-004127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919123004127/doc4.xml","form_type":"4"}},{"id":2120402,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":9825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":694779,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":9825},"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120401,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":18175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":18175},"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120400,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":18175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120399,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":9825,"price":20,"value":196500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120398,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":9825,"price":5.04,"value":49518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":264379,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120397,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":18175,"price":20,"value":363500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120396,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":18175,"price":4.12,"value":74881.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":272729,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120395,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":14000,"price":20.18,"value":282520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.00 to $20.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2120394,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-10T22:13:23.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-056427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122056427/doc4.xml","form_type":"4"}},{"id":2137907,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":32175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137906,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-12","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":46175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137905,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-11","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":60175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137904,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-13","kind":"sale","acquired":false,"shares":14000,"price":20.58,"value":288120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $20.28 to $20.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137903,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137902,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-12","kind":"sale","acquired":false,"shares":14000,"price":21.18,"value":296520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.78 to $21.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137901,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-12","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137900,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":14000,"price":21.36,"value":299040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.76 to $21.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2137899,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-13T22:09:47.000Z","date":"2022-10-11","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-053597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122053597/doc4.xml","form_type":"4"}},{"id":2158785,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":74175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158784,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-14","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":88175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158783,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-13","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":102175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158782,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":14000,"price":23.8,"value":333200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $23.36 to $24.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158781,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158780,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":14000,"price":23.47,"value":328580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $22.89 to $24.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158779,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-14","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158778,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":14000,"price":25.45,"value":356300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.99 to $26.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2158777,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T01:02:55.000Z","date":"2022-09-13","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 22, 2022."}],"balance_after":268554,"source":{"system":"sec-edgar","filing":"0001209191-22-050182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122050182/doc4.xml","form_type":"4"}},{"id":2210264,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-08T20:22:36.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":814,"price":14.24,"value":11591.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2022."}],"balance_after":254554,"source":{"system":"sec-edgar","filing":"0001209191-22-041639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122041639/doc4.xml","form_type":"4"}},{"id":2254277,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-28T01:30:56.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2023 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":25.6,"expiration_date":"2032-05-18","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-22-021109","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000114036122021109/form4.xml","form_type":"4"}},{"id":2297301,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":704604,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297300,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":116175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297299,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":718604,"derivative":{"exercise_price":5.04,"expiration_date":"2029-04-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297298,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":130175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297297,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-12","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":144175,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297296,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":14000,"price":30.51,"value":427140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $32.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297295,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"exercise","acquired":true,"shares":14000,"price":5.04,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."}],"balance_after":267740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297294,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"sale","acquired":false,"shares":14000,"price":30.51,"value":427140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $32.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297293,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-14","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."}],"balance_after":267740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297292,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":14000,"price":31.94,"value":447160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $31.43 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297291,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":14000,"price":5.04,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."}],"balance_after":267740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297290,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":14000,"price":31.96,"value":447440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $31.48 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297289,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":14000,"price":4.12,"value":57680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."}],"balance_after":267740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297288,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-12","kind":"sale","acquired":false,"shares":28000,"price":31.8,"value":890400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.89 to $32.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2297287,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-15T01:20:21.000Z","date":"2022-04-12","kind":"exercise","acquired":true,"shares":28000,"price":4.12,"value":115360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021."}],"balance_after":281740,"source":{"system":"sec-edgar","filing":"0001209191-22-024487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122024487/doc4.xml","form_type":"4"}},{"id":2421608,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T22:25:11.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":527140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":527140,"derivative":{"exercise_price":20.38,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":527140},"source":{"system":"sec-edgar","filing":"0001209191-22-005675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122005675/doc4.xml","form_type":"4"}},{"id":2440663,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-07T22:13:41.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":658,"price":26.1,"value":17173.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021."}],"balance_after":253740,"source":{"system":"sec-edgar","filing":"0001209191-22-002465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000120919122002465/doc4.xml","form_type":"4"}},{"id":2701776,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":22520,"kind":"person","name":"Patel Sanjiv","position":1,"cik":"0001816210","reported_name":"Patel Sanjiv","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T21:05:45.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 33 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 1/3% on the second anniversary of the grant date, and the remaining 33 1/3% on the earlier of the third anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":23.97,"expiration_date":"2031-05-19","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-010961","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816210/000156761921010961/doc1.xml","form_type":"4"}}],"next_cursor":"2021-05-21T21:05:45.000000Z,2701776"}